These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27427125)

  • 1. Evaluation of QT parameters in patients of thalassaemia major with iron overload.
    Faruqi A; Ahmad SI; Ahmed ST
    J Pak Med Assoc; 2016 Jul; 66(7):799-802. PubMed ID: 27427125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of QT dispersion in beta thalassaemia major patients.
    Ulger Z; Aydinok Y; Levent E; Gurses D; Ozyurek AR
    Am J Hematol; 2006 Dec; 81(12):901-6. PubMed ID: 16924653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-existing iron deficiency/overload in beta-thalassemia trait.
    Yousafzai YM; Wahid QUA; Khan S; Mir A; Khan A; Raziq F
    J Pak Med Assoc; 2019 Jun; 69(6):806-810. PubMed ID: 31189286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased iron stores prolong the QT interval - a general population study including 20 261 individuals and meta-analysis of thalassaemia major.
    Henriksen LF; Petri AS; Hasselbalch HC; Kanters JK; Ellervik C
    Br J Haematol; 2016 Sep; 174(5):776-85. PubMed ID: 27062493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia.
    Chang HH; Chen MJ; Lu MY; Chern JP; Lu CY; Yang YL; Jou ST; Lin DT; Yang YS; Lin KH
    BJOG; 2011 Jun; 118(7):825-31. PubMed ID: 21401854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients.
    Koonrungsesomboon N; Tantiworawit A; Phrommintikul A; Saekho S; Srichairattanakool S; Chattipakorn N
    Hemoglobin; 2015; 39(4):281-6. PubMed ID: 26029793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between T2* cardiovascular magnetic resonance with left ventricular function and mass in adolescent and adult major thalassemia patients with iron overload.
    Djer MM; Anggriawan SL; Gatot D; Amalia P; Sastroasmoro S; Widjaja P
    Acta Med Indones; 2013 Oct; 45(4):295-301. PubMed ID: 24448334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid function in thalassaemia major.
    Senanayake MP; Suraweera SA; Hubert HD
    Ceylon Med J; 1999 Dec; 44(4):166-8. PubMed ID: 10895267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
    Chuansumrit A; Laothamathat J; Sirachainan N; Sungkarat W; Wongwerawattanakoon P; Kumkrua P
    Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia.
    Karimi M; Arandi N; Haghpanah S; Ansari S; Azarkeyvan A; Bordbar M; Safaei S
    Hemoglobin; 2015; 39(5):327-9. PubMed ID: 26114738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
    De Sanctis V; De Sanctis E; Ricchieri P; Gubellini E; Gilli G; Gamberini MR
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major.
    Telfer PT; Prestcott E; Holden S; Walker M; Hoffbrand AV; Wonke B
    Br J Haematol; 2000 Sep; 110(4):971-7. PubMed ID: 11054091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron overload.
    Luckie M; Irwin B; Nair S; Greenwood J; Khattar R
    Eur J Echocardiogr; 2009 Jun; 10(4):509-12. PubMed ID: 19091793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between iron stores and corrected QT dispersion in patients undergoing hemodialysis.
    Dervişoğlu E; Yilmaz A; Sevin E; Kalender B
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):270-4. PubMed ID: 17785215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia.
    Ladis V; Berdousi H; Gotsis E; Kattamis A
    Br J Haematol; 2010 Dec; 151(5):504-8. PubMed ID: 20950401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control.
    Suriapperuma T; Peiris R; Mettananda C; Premawardhena A; Mettananda S
    BMC Res Notes; 2018 Aug; 11(1):547. PubMed ID: 30071883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.